After Ranbaxy Labs sales in 2008, there is one more big M & A for year 2009, i.e. sale of Wockhardt biotechnology and veterinary division, According to some reports US drug major Pfizer is reportedly in an advanced stage of talks with Wockhardt to acquire its biotechnology and veterinary divisions, the deal, which could value Wockhardt's comparatively smaller businesses is of worth around Rs 1.2bn.
Tuesday, June 16, 2009
After Ranbaxy Labs its Wockhradt in news ....
After Ranbaxy Labs sales in 2008, there is one more big M & A for year 2009, i.e. sale of Wockhardt biotechnology and veterinary division, According to some reports US drug major Pfizer is reportedly in an advanced stage of talks with Wockhardt to acquire its biotechnology and veterinary divisions, the deal, which could value Wockhardt's comparatively smaller businesses is of worth around Rs 1.2bn.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment